Institutional Ownership Reneo Pharmaceuticals, Inc. (RPHM)
This table provides information about the institutional ownership of Reneo Pharmaceuticals, Inc. (RPHM). We have compiled data on the 4 institutions that hold shares in the stock, with a total of 4.9 Million shares, which have been reported (via 13F filing form) to have a value of $8.24 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
River Vest Venture Management LLC
St. Louis, MO |
Oct 30, 2024 Q3 2024 |
2,534,220
shares
|
$4.26 Million
63.0% of portfolio
|
Q2 2023
Added 5.19%
|
|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
2,073,957
shares
|
$3.48 Million
1.6% of portfolio
|
Q3 2021
Added 5.69%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
293,651
shares
|
$493,333
0.0% of portfolio
|
Q2 2024
Reduced 70.45%
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Feb 07, 2025 Q4 2024 |
1,526
shares
|
$2,563
0.0% of portfolio
|
Q3 2024
New holding
|